174
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method

, , , , , , & show all
Pages 1661-1675 | Published online: 10 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yue Yu, Zhou Wang, Ran Wang, Jing Jin & Yi Zhun Zhu. (2021) Short-Term Oral Administration of Mesoporous Silica Nanoparticles Potentially Induced Colon Inflammation in Rats Through Alteration of Gut Microbiota. International Journal of Nanomedicine 16, pages 881-893.
Read now

Articles from other publishers (8)

Delaram Kargari Aghmiouni & Sepideh Khoee. (2023) Dual-Drug Delivery by Anisotropic and Uniform Hybrid Nanostructures: A Comparative Study of the Function and Substrate–Drug Interaction Properties. Pharmaceutics 15:4, pages 1214.
Crossref
Adejumoke Lara Ajiboye, Amélie Jacopin, Claudia Mattern, Uttom Nandi, Andrew Hurt & Vivek Trivedi. (2022) Dissolution Improvement of Progesterone and Testosterone via Impregnation on Mesoporous Silica Using Supercritical Carbon Dioxide. AAPS PharmSciTech 23:8.
Crossref
Vancha Harish, Md Mustafiz Ansari, Devesh Tewari, Manish Gaur, Awadh Bihari Yadav, María-Luisa García-Betancourt, Fatehy M. Abdel-Haleem, Mikhael Bechelany & Ahmed Barhoum. (2022) Nanoparticle and Nanostructure Synthesis and Controlled Growth Methods. Nanomaterials 12:18, pages 3226.
Crossref
Chang Yang, Qing Zhao, Shanshan Yang, Libin Wang, Xingyuan Xu, Lisu Li & Wafa T. Al-Jamal. (2022) Intravenous Administration of Scutellarin Nanoparticles Augments the Protective Effect against Cerebral Ischemia–Reperfusion Injury in Rats. Molecular Pharmaceutics 19:5, pages 1410-1421.
Crossref
Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J. Cabot, Nazrul Islam & Emad L. Izake. (2022) β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics 14:4, pages 884.
Crossref
Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J. Cabot, Nazrul Islam & Emad L. Izake. (2021) PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells. Pharmaceutics 13:10, pages 1605.
Crossref
Delaram Babadi, Simin Dadashzadeh, Mahraz Osouli, Zahra Abbasian, Maryam Sadat Daryabari, Sima Sadrai & Azadeh Haeri. (2021) Biopharmaceutical and pharmacokinetic aspects of nanocarrier-mediated oral delivery of poorly soluble drugs. Journal of Drug Delivery Science and Technology 62, pages 102324.
Crossref
Khaled AbouAitah & Witold Lojkowski. (2021) Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy. Pharmaceutics 13:2, pages 143.
Crossref